Precision Medicine for Autoimmunity: Mechanism of Action for CAAR-T Cell Therapy & Applications to B Cell-Mediated Autoimmune Disease

Time: 11:00 am
day: Day 2 - Track B - Morning


• Reviewing mechanism of action for the CAAR-T platform that is designed to recognise and eliminate only the B-cells that cause autoimmune disease in patients
• Discussing emerging clinical and translational insights from DesCAARTes trial of DSG3-CAART
• Sharing rationale for indication prioritisation along with pre-clinical development path for new product candidates